(Q40214416)

18 September 2017

Gene expression response to cisplatin treatment in drug-sensitive and drug-resistant ovarian cancer cells (English)

1 reference

18 September 2017

1 reference

1 reference

3

1 reference

18 September 2017

J Li

1

1 reference

18 September 2017

W H Wood

series ordinal

2

1 reference

18 September 2017

A T Weeraratna

series ordinal

4

1 reference

18 September 2017

P J Morin

series ordinal

5

1 reference

18 September 2017

language of work or name

English

0 references

publication date

30 October 2006

1 reference

18 September 2017

1 reference

18 September 2017

26

1 reference

18 September 2017

20

1 reference

18 September 2017

2860-2872

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1210086

18 September 2017

0 references

cites work

Genetic and expression profiles of squamous cell carcinoma of the head and neck correlate with cisplatin sensitivity and resistance in cell lines and patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210086

Stress-specific signatures: expression profiling of p53 wild-type and -null human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210086

Increased accumulation of p53 protein in cisplatin-resistant ovarian cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210086

Disruption of p53 in human cancer cells alters the responses to therapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210086

p53 alterations are predictive of chemoresistance and aggressiveness in ovarian carcinomas: a molecular and immunohistochemical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210086

Identification of genes whose expression is associated with cisplatin resistance in human ovarian carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210086

The tumor microenvironment as a determinant of drug response and resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210086

DDP-induced cytotoxicity is not influenced by p53 in nine human ovarian cancer cell lines with different p53 status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210086

Curing metastatic testicular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210086

Scrape-loading and dye transfer. A rapid and simple technique to study gap junctional intercellular communication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210086

Neoplastic reversal of human ovarian carcinoma cells transfected with connexin43.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210086

Glypicans in growth control and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210086

Identification of genes with differential expression in acquired drug-resistant gastric cancer cells using high-density oligonucleotide microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210086

Mechanisms of resistance to cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210086

A p53-dominant transcriptional response to cisplatin in testicular germ cell tumor-derived human embryonal carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210086

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210086

p53-dependent apoptosis modulates the cytotoxicity of anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210086

Twist is a potential oncogene that inhibits apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210086

Influence of the proto-oncogene c-fos on cisplatin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210086

Drug resistance and the microenvironment: nature and nurture

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210086

Identification of genes associated with platinum drug sensitivity and resistance in human ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210086

Regulation and function of the p53 tumor suppressor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210086

p53 downstream targets and chemosensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210086

Cloning, up-regulation, and mitogenic role of porcine P2Y2 receptor in coronary artery smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210086

Remodeling of the extracellular matrix through overexpression of collagen VI contributes to cisplatin resistance in ovarian cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210086

Cisplatin: mode of cytotoxic action and molecular basis of resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210086

Predicting response to methotrexate, vinblastine, doxorubicin, and cisplatin neoadjuvant chemotherapy for bladder cancers through genome-wide gene expression profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210086

Induction of a bystander effect in HeLa cells by using a bigenic vector carrying viral thymidine kinase and connexin32 genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210086

Regulation of life and death by the zinc finger transcription factor Egr-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210086

Identification of a novel function of TWIST, a bHLH protein, in the development of acquired taxol resistance in human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210086

Molecular mechanisms of platinum resistance: still searching for the Achilles' heel

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210086

A novel time-course cDNA microarray analysis method identifies genes associated with the development of cisplatin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210086

Intercellular communication is involved in the bystander regulation of gene expression in human cells exposed to very low fluences of alpha particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210086

7 January 2021

Reduced expression of retinoblastoma gene product (pRB) and high expression of p53 are associated with poor prognosis in ovarian cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210086

7 January 2021

Changes in the cytoskeleton pattern of tumor cells by cisplatin in vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210086

7 January 2021

Connexin mediates gap junction-independent resistance to cellular injury.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210086

7 January 2021

Effect of p53 status on sensitivity to platinum complexes in a human ovarian cancer cell line.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210086

7 January 2021

Characterisation of the p53 status, BCL-2 expression and radiation and platinum drug sensitivity of a panel of human ovarian cancer cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210086

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1210086

1 reference

Dimensions Publication ID

18 September 2017

0 references

1 reference